Insider Transactions in Q2 2025 at Neuro Bo Pharmaceuticals, Inc. (NRBO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Michael Salsbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,147
+38.12%
|
-
|
|
Jun 30
2025
|
Andrew I Koven Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,147
+38.12%
|
-
|
|
Jun 30
2025
|
D Gordon Strickland Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,147
+38.12%
|
-
|
|
Jun 30
2025
|
James Patrick Tursi Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,147
+43.06%
|
-
|
|
Jun 30
2025
|
Jason L Groves Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,147
+38.12%
|
-
|
|
Jun 30
2025
|
Mark A Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,147
+42.63%
|
-
|
|
Jun 04
2025
|
Marshall H Woodworth Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
14,200
+24.28%
|
$0
$0.7 P/Share
|
|
May 08
2025
|
Dong A St Co., LTD |
BUY
Open market or private purchase
|
Direct |
4,647,887
+31.74%
|
$0
$0.71 P/Share
|